104 related articles for article (PubMed ID: 1826985)
1. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans.
Nordøy A; Barstad L; Connor WE; Hatcher L
Am J Clin Nutr; 1991 May; 53(5):1185-90. PubMed ID: 1826985
[TBL] [Abstract][Full Text] [Related]
2. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
Qin Y; Nyheim H; Haram EM; Moritz JM; Hustvedt SO
Lipids Health Dis; 2017 Oct; 16(1):204. PubMed ID: 29037249
[TBL] [Abstract][Full Text] [Related]
3. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters.
Neubronner J; Schuchardt JP; Kressel G; Merkel M; von Schacky C; Hahn A
Eur J Clin Nutr; 2011 Feb; 65(2):247-54. PubMed ID: 21063431
[TBL] [Abstract][Full Text] [Related]
4. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters.
Lawson LD; Hughes BG
Biochem Biophys Res Commun; 1988 Apr; 152(1):328-35. PubMed ID: 3358766
[TBL] [Abstract][Full Text] [Related]
5. [Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers].
Beckermann B; Beneke M; Seitz I
Arzneimittelforschung; 1990 Jun; 40(6):700-4. PubMed ID: 2144420
[TBL] [Abstract][Full Text] [Related]
6. Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal.
Lawson LD; Hughes BG
Biochem Biophys Res Commun; 1988 Oct; 156(2):960-3. PubMed ID: 2847723
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J; Madsen P; Møller JM; Aardestrup I; Schmidt EB
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):137-41. PubMed ID: 20638827
[TBL] [Abstract][Full Text] [Related]
8. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
Krokan HE; Bjerve KS; Mørk E
Biochim Biophys Acta; 1993 May; 1168(1):59-67. PubMed ID: 8504143
[TBL] [Abstract][Full Text] [Related]
9. Digestion and lymphatic transport of eicosapentaenoic and docosahexaenoic acids given in the form of triacylglycerol, free acid and ethyl ester in rats.
Ikeda I; Sasaki E; Yasunami H; Nomiyama S; Nakayama M; Sugano M; Imaizumi K; Yazawa K
Biochim Biophys Acta; 1995 Dec; 1259(3):297-304. PubMed ID: 8541338
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 long chain fatty acid "bioavailability": a review of evidence and methodological considerations.
Ghasemifard S; Turchini GM; Sinclair AJ
Prog Lipid Res; 2014 Oct; 56():92-108. PubMed ID: 25218856
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil.
Schuchardt JP; Schneider I; Meyer H; Neubronner J; von Schacky C; Hahn A
Lipids Health Dis; 2011 Aug; 10():145. PubMed ID: 21854650
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers.
Rusca A; Di Stefano AF; Doig MV; Scarsi C; Perucca E
Eur J Clin Pharmacol; 2009 May; 65(5):503-10. PubMed ID: 19148629
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
Galli C; Maggi FM; Risé P; Sirtori CR
Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men.
Hansen JB; Olsen JO; Wilsgård L; Lyngmo V; Svensson B
Eur J Clin Nutr; 1993 Jul; 47(7):497-507. PubMed ID: 8404785
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Kwak SM; Myung SK; Lee YJ; Seo HG;
Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
[TBL] [Abstract][Full Text] [Related]
16. Lipolysis of menhaden oil triacylglycerols and the corresponding fatty acid alkyl esters by pancreatic lipase in vitro: a reexamination.
Yang LY; Kuksis A; Myher JJ
J Lipid Res; 1990 Jan; 31(1):137-47. PubMed ID: 2313198
[TBL] [Abstract][Full Text] [Related]
17. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M
Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374
[TBL] [Abstract][Full Text] [Related]
18. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
Davidson MH; Johnson J; Rooney MW; Kyle ML; Kling DF
J Clin Lipidol; 2012; 6(6):573-84. PubMed ID: 23312053
[TBL] [Abstract][Full Text] [Related]
19. Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil.
Raatz SK; Redmon JB; Wimmergren N; Donadio JV; Bibus DM
J Am Diet Assoc; 2009 Jun; 109(6):1076-81. PubMed ID: 19465191
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of long-chain omega-3 fatty acids.
Schuchardt JP; Hahn A
Prostaglandins Leukot Essent Fatty Acids; 2013 Jul; 89(1):1-8. PubMed ID: 23676322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
